| UniProt ID | MPLKI_HUMAN | |
|---|---|---|
| UniProt AC | Q8TAP9 | |
| Protein Name | M-phase-specific PLK1-interacting protein | |
| Gene Name | MPLKIP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 179 | |
| Subcellular Localization | Nucleus. Cytoplasm. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. The subcellular location is regulated during cell cycle. During interphase located in the nucleus. During mitosis located at the centrosome and dispersed in the c | |
| Protein Description | May play a role in maintenance of cell cycle integrity by regulating mitosis or cytokinesis.. | |
| Protein Sequence | MQRQNFRPPTPPYPGPGGGGWGSGSSFRGTPGGGGPRPPSPRDGYGSPHHTPPYGPRSRPYGSSHSPRHGGSFPGGRFGSPSPGGYPGSYSRSPAGSQQQFGYSPGQQQTHPQGSPRTSTPFGSGRVREKRMSNELENYFKPSMLEDPWAGLEPVSVVDISQQYSNTQTFTGKKGRYFC | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Methylation | -MQRQNFRPPTPPYP -CCCCCCCCCCCCCC | 43.78 | 24376955 | |
| 7 | Dimethylation | -MQRQNFRPPTPPYP -CCCCCCCCCCCCCC | 43.78 | - | |
| 10 | Phosphorylation | RQNFRPPTPPYPGPG CCCCCCCCCCCCCCC | 39.31 | 22617229 | |
| 13 | Phosphorylation | FRPPTPPYPGPGGGG CCCCCCCCCCCCCCC | 23.25 | 23898821 | |
| 23 | Phosphorylation | PGGGGWGSGSSFRGT CCCCCCCCCCCCCCC | 29.06 | 26074081 | |
| 25 | Phosphorylation | GGGWGSGSSFRGTPG CCCCCCCCCCCCCCC | 28.18 | 26074081 | |
| 26 | Phosphorylation | GGWGSGSSFRGTPGG CCCCCCCCCCCCCCC | 23.61 | 26074081 | |
| 28 | Methylation | WGSGSSFRGTPGGGG CCCCCCCCCCCCCCC | 50.45 | 24376965 | |
| 28 | Dimethylation | WGSGSSFRGTPGGGG CCCCCCCCCCCCCCC | 50.45 | - | |
| 30 | Phosphorylation | SGSSFRGTPGGGGPR CCCCCCCCCCCCCCC | 17.95 | 26055452 | |
| 37 | Asymmetric dimethylarginine | TPGGGGPRPPSPRDG CCCCCCCCCCCCCCC | 60.06 | - | |
| 37 | Methylation | TPGGGGPRPPSPRDG CCCCCCCCCCCCCCC | 60.06 | 24376975 | |
| 40 | Phosphorylation | GGGPRPPSPRDGYGS CCCCCCCCCCCCCCC | 34.94 | 30266825 | |
| 42 | Dimethylation | GPRPPSPRDGYGSPH CCCCCCCCCCCCCCC | 55.08 | - | |
| 42 | Methylation | GPRPPSPRDGYGSPH CCCCCCCCCCCCCCC | 55.08 | 30763419 | |
| 45 | Phosphorylation | PPSPRDGYGSPHHTP CCCCCCCCCCCCCCC | 20.79 | 23927012 | |
| 47 | Phosphorylation | SPRDGYGSPHHTPPY CCCCCCCCCCCCCCC | 16.75 | 23401153 | |
| 51 | Phosphorylation | GYGSPHHTPPYGPRS CCCCCCCCCCCCCCC | 23.95 | 23401153 | |
| 54 | Phosphorylation | SPHHTPPYGPRSRPY CCCCCCCCCCCCCCC | 40.75 | 28450419 | |
| 57 | Methylation | HTPPYGPRSRPYGSS CCCCCCCCCCCCCCC | 40.72 | 24129315 | |
| 57 | Dimethylation | HTPPYGPRSRPYGSS CCCCCCCCCCCCCCC | 40.72 | - | |
| 58 | Phosphorylation | TPPYGPRSRPYGSSH CCCCCCCCCCCCCCC | 40.52 | 26270265 | |
| 59 | Methylation | PPYGPRSRPYGSSHS CCCCCCCCCCCCCCC | 29.73 | 24129315 | |
| 59 | Asymmetric dimethylarginine | PPYGPRSRPYGSSHS CCCCCCCCCCCCCCC | 29.73 | - | |
| 61 | Phosphorylation | YGPRSRPYGSSHSPR CCCCCCCCCCCCCCC | 28.64 | 26270265 | |
| 63 | Phosphorylation | PRSRPYGSSHSPRHG CCCCCCCCCCCCCCC | 21.02 | 29978859 | |
| 64 | Phosphorylation | RSRPYGSSHSPRHGG CCCCCCCCCCCCCCC | 24.50 | 27732954 | |
| 66 | Phosphorylation | RPYGSSHSPRHGGSF CCCCCCCCCCCCCCC | 26.10 | 29496963 | |
| 68 | Methylation | YGSSHSPRHGGSFPG CCCCCCCCCCCCCCC | 44.06 | 24129315 | |
| 68 | Asymmetric dimethylarginine | YGSSHSPRHGGSFPG CCCCCCCCCCCCCCC | 44.06 | - | |
| 72 | Phosphorylation | HSPRHGGSFPGGRFG CCCCCCCCCCCCCCC | 32.62 | 25159151 | |
| 77 | Asymmetric dimethylarginine | GGSFPGGRFGSPSPG CCCCCCCCCCCCCCC | 38.37 | - | |
| 77 | Methylation | GGSFPGGRFGSPSPG CCCCCCCCCCCCCCC | 38.37 | 24129315 | |
| 80 | Phosphorylation | FPGGRFGSPSPGGYP CCCCCCCCCCCCCCC | 21.35 | 25159151 | |
| 82 | Phosphorylation | GGRFGSPSPGGYPGS CCCCCCCCCCCCCCC | 37.56 | 25159151 | |
| 89 | Phosphorylation | SPGGYPGSYSRSPAG CCCCCCCCCCCCCCC | 18.54 | 26425664 | |
| 91 | Phosphorylation | GGYPGSYSRSPAGSQ CCCCCCCCCCCCCCC | 28.16 | - | |
| 92 | Methylation | GYPGSYSRSPAGSQQ CCCCCCCCCCCCCCC | 38.13 | 115919105 | |
| 93 | Phosphorylation | YPGSYSRSPAGSQQQ CCCCCCCCCCCCCCC | 17.11 | 23401153 | |
| 97 | Phosphorylation | YSRSPAGSQQQFGYS CCCCCCCCCCCCCCC | 27.24 | 23927012 | |
| 103 | Phosphorylation | GSQQQFGYSPGQQQT CCCCCCCCCCCCCCC | 17.00 | 23927012 | |
| 104 | Phosphorylation | SQQQFGYSPGQQQTH CCCCCCCCCCCCCCC | 23.96 | 23927012 | |
| 110 | Phosphorylation | YSPGQQQTHPQGSPR CCCCCCCCCCCCCCC | 31.05 | 22167270 | |
| 115 | Phosphorylation | QQTHPQGSPRTSTPF CCCCCCCCCCCCCCC | 13.13 | 22167270 | |
| 117 | Methylation | THPQGSPRTSTPFGS CCCCCCCCCCCCCCC | 42.90 | 24129315 | |
| 117 | Dimethylation | THPQGSPRTSTPFGS CCCCCCCCCCCCCCC | 42.90 | - | |
| 118 | Phosphorylation | HPQGSPRTSTPFGSG CCCCCCCCCCCCCCH | 40.09 | 29396449 | |
| 119 | Phosphorylation | PQGSPRTSTPFGSGR CCCCCCCCCCCCCHH | 35.05 | 20068231 | |
| 120 | Phosphorylation | QGSPRTSTPFGSGRV CCCCCCCCCCCCHHH | 23.25 | 25159151 | |
| 124 | Phosphorylation | RTSTPFGSGRVREKR CCCCCCCCHHHCHHH | 24.65 | 23401153 | |
| 126 | Methylation | STPFGSGRVREKRMS CCCCCCHHHCHHHHH | 26.47 | 58860199 | |
| 126 | Dimethylation | STPFGSGRVREKRMS CCCCCCHHHCHHHHH | 26.47 | - | |
| 133 | Phosphorylation | RVREKRMSNELENYF HHCHHHHHHHHHHHC | 31.05 | 19664994 | |
| 139 | Phosphorylation | MSNELENYFKPSMLE HHHHHHHHCCHHHHC | 12.01 | 30108239 | |
| 143 | Phosphorylation | LENYFKPSMLEDPWA HHHHCCHHHHCCCCC | 36.27 | 20068231 | |
| 156 | Phosphorylation | WAGLEPVSVVDISQQ CCCCCCEEEEEHHHH | 27.43 | 20068231 | |
| 161 | Phosphorylation | PVSVVDISQQYSNTQ CEEEEEHHHHCCCCC | 13.53 | 20068231 | |
| 164 | Phosphorylation | VVDISQQYSNTQTFT EEEHHHHCCCCCEEC | 9.03 | 20068231 | |
| 165 | Phosphorylation | VDISQQYSNTQTFTG EEHHHHCCCCCEECC | 29.12 | 20068231 | |
| 167 | Phosphorylation | ISQQYSNTQTFTGKK HHHHCCCCCEECCCC | 24.05 | 20068231 | |
| 169 | Phosphorylation | QQYSNTQTFTGKKGR HHCCCCCEECCCCCC | 22.56 | 20068231 | |
| 171 | Phosphorylation | YSNTQTFTGKKGRYF CCCCCEECCCCCCCC | 52.02 | 20068231 | |
| 173 | Acetylation | NTQTFTGKKGRYFC- CCCEECCCCCCCCC- | 49.34 | 30593139 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MPLKI_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MPLKI_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of MPLKI_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 234050 | Trichothiodystrophy 4, non-photosensitive (TTD4) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-45; SER-47; THR-51;SER-72; SER-80; SER-82; SER-93; SER-104; SER-115; THR-120 AND SER-124,AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-13; SER-72; SER-80;SER-82; SER-93; SER-115; THR-120 AND SER-133, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-45; SER-47 AND THR-51,AND MASS SPECTROMETRY. | |
| "TTDN1 is a Plk1-interacting protein involved in maintenance of cellcycle integrity."; Zhang Y., Tian Y., Chen Q., Chen D., Zhai Z., Shu H.-B.; Cell. Mol. Life Sci. 64:632-640(2007). Cited for: FUNCTION, INTERACTION WITH PLK1, SUBCELLULAR LOCATION, MUTAGENESIS OFSER-93; SER-104 AND THR-120, AND PHOSPHORYLATION AT SER-93 ANDSER-104. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-120, AND MASSSPECTROMETRY. | |